Botulinum Toxin in Treatments for Abnormal Movements

Introduction: Botulinum toxin is crucial for reducing sequelae in movement disorders such as Parkinson's. It blocks muscle contractions and improves quality of life, being used in both aesthetic and medical treatments. Methodology: A non-experimental longitudinal design was adopted, observing v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Más Vita 2024-07, Vol.6 (2), p.82-92
Hauptverfasser: González Chico, María Gabriela, Medina Godoy, Xaviera Elizabeth, Estupiñan Bazurto, Miliana Esperanza, López Becerra, María José
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 92
container_issue 2
container_start_page 82
container_title Más Vita
container_volume 6
creator González Chico, María Gabriela
Medina Godoy, Xaviera Elizabeth
Estupiñan Bazurto, Miliana Esperanza
López Becerra, María José
description Introduction: Botulinum toxin is crucial for reducing sequelae in movement disorders such as Parkinson's. It blocks muscle contractions and improves quality of life, being used in both aesthetic and medical treatments. Methodology: A non-experimental longitudinal design was adopted, observing variables at multiple time points without manipulation. A mixed approach (qualitative and quantitative) was used with adults over 30 years old without Parkinson's history. The review included documents from PubMed, Scopus, and Scielo, applying rigorous inclusion and exclusion criteria. Objective: To evaluate the efficacy of botulinum toxin in treating abnormal movements in Parkinson's and understand its long-term effects. Results: Botulinum toxin type A reduces tremors by blocking acetylcholine. It improves motor symptoms of Parkinson's and essential tremor but requires frequent and costly treatments. There is a risk of developing antibodies that decrease its effectiveness. Discussion: It offers significant benefits, but its high cost and the need for frequent treatments are challenges. Patients report satisfaction in short-term studies, but more long-term research is needed. Conclusions: Promising for movement disorders, especially Parkinson's, although limited by cost and duration of effect. Future research should seek to extend therapeutic effects and reduce costs.
doi_str_mv 10.47606/ACVEN/MV0235
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_47606_ACVEN_MV0235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_47606_ACVEN_MV0235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c775-53b746dca72673a34ddfff8b7c9a605c2b360e62e1ff1afa412db201257575d93</originalsourceid><addsrcrecordid>eNpNj01LxDAYhIMouKx79J4_EPfN1xt7rGX9gF29lL2WpE2g0DaSdEX_vUvXg8zADHMYeAi55_CgDAJuy-q4e98ejiCkviIrgagZcA3X__ot2eTcO1CIAgouVkQ9xfk09NNppHX87id6dp28nUc_zZmGmGjppphGO9BD_PLLfEdugh2y3_zlmtTPu7p6ZfuPl7eq3LPWGM20dEZh11oj0EgrVdeFEB6daQuLoFvhJIJH4XkI3AaruOicAC60Oasr5Jqwy22bYs7Jh-Yz9aNNPw2HZoFuFujmAi1_ASUySgs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Botulinum Toxin in Treatments for Abnormal Movements</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>González Chico, María Gabriela ; Medina Godoy, Xaviera Elizabeth ; Estupiñan Bazurto, Miliana Esperanza ; López Becerra, María José</creator><creatorcontrib>González Chico, María Gabriela ; Medina Godoy, Xaviera Elizabeth ; Estupiñan Bazurto, Miliana Esperanza ; López Becerra, María José</creatorcontrib><description>Introduction: Botulinum toxin is crucial for reducing sequelae in movement disorders such as Parkinson's. It blocks muscle contractions and improves quality of life, being used in both aesthetic and medical treatments. Methodology: A non-experimental longitudinal design was adopted, observing variables at multiple time points without manipulation. A mixed approach (qualitative and quantitative) was used with adults over 30 years old without Parkinson's history. The review included documents from PubMed, Scopus, and Scielo, applying rigorous inclusion and exclusion criteria. Objective: To evaluate the efficacy of botulinum toxin in treating abnormal movements in Parkinson's and understand its long-term effects. Results: Botulinum toxin type A reduces tremors by blocking acetylcholine. It improves motor symptoms of Parkinson's and essential tremor but requires frequent and costly treatments. There is a risk of developing antibodies that decrease its effectiveness. Discussion: It offers significant benefits, but its high cost and the need for frequent treatments are challenges. Patients report satisfaction in short-term studies, but more long-term research is needed. Conclusions: Promising for movement disorders, especially Parkinson's, although limited by cost and duration of effect. Future research should seek to extend therapeutic effects and reduce costs.</description><identifier>ISSN: 2665-0150</identifier><identifier>EISSN: 2665-0150</identifier><identifier>DOI: 10.47606/ACVEN/MV0235</identifier><language>eng</language><ispartof>Más Vita, 2024-07, Vol.6 (2), p.82-92</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c775-53b746dca72673a34ddfff8b7c9a605c2b360e62e1ff1afa412db201257575d93</cites><orcidid>0009-0009-7331-8590 ; 0009-0001-3813-5790 ; 0009-0007-0613-0016 ; 0000-0001-9445-9004</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>González Chico, María Gabriela</creatorcontrib><creatorcontrib>Medina Godoy, Xaviera Elizabeth</creatorcontrib><creatorcontrib>Estupiñan Bazurto, Miliana Esperanza</creatorcontrib><creatorcontrib>López Becerra, María José</creatorcontrib><title>Botulinum Toxin in Treatments for Abnormal Movements</title><title>Más Vita</title><description>Introduction: Botulinum toxin is crucial for reducing sequelae in movement disorders such as Parkinson's. It blocks muscle contractions and improves quality of life, being used in both aesthetic and medical treatments. Methodology: A non-experimental longitudinal design was adopted, observing variables at multiple time points without manipulation. A mixed approach (qualitative and quantitative) was used with adults over 30 years old without Parkinson's history. The review included documents from PubMed, Scopus, and Scielo, applying rigorous inclusion and exclusion criteria. Objective: To evaluate the efficacy of botulinum toxin in treating abnormal movements in Parkinson's and understand its long-term effects. Results: Botulinum toxin type A reduces tremors by blocking acetylcholine. It improves motor symptoms of Parkinson's and essential tremor but requires frequent and costly treatments. There is a risk of developing antibodies that decrease its effectiveness. Discussion: It offers significant benefits, but its high cost and the need for frequent treatments are challenges. Patients report satisfaction in short-term studies, but more long-term research is needed. Conclusions: Promising for movement disorders, especially Parkinson's, although limited by cost and duration of effect. Future research should seek to extend therapeutic effects and reduce costs.</description><issn>2665-0150</issn><issn>2665-0150</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNj01LxDAYhIMouKx79J4_EPfN1xt7rGX9gF29lL2WpE2g0DaSdEX_vUvXg8zADHMYeAi55_CgDAJuy-q4e98ejiCkviIrgagZcA3X__ot2eTcO1CIAgouVkQ9xfk09NNppHX87id6dp28nUc_zZmGmGjppphGO9BD_PLLfEdugh2y3_zlmtTPu7p6ZfuPl7eq3LPWGM20dEZh11oj0EgrVdeFEB6daQuLoFvhJIJH4XkI3AaruOicAC60Oasr5Jqwy22bYs7Jh-Yz9aNNPw2HZoFuFujmAi1_ASUySgs</recordid><startdate>20240702</startdate><enddate>20240702</enddate><creator>González Chico, María Gabriela</creator><creator>Medina Godoy, Xaviera Elizabeth</creator><creator>Estupiñan Bazurto, Miliana Esperanza</creator><creator>López Becerra, María José</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0009-0009-7331-8590</orcidid><orcidid>https://orcid.org/0009-0001-3813-5790</orcidid><orcidid>https://orcid.org/0009-0007-0613-0016</orcidid><orcidid>https://orcid.org/0000-0001-9445-9004</orcidid></search><sort><creationdate>20240702</creationdate><title>Botulinum Toxin in Treatments for Abnormal Movements</title><author>González Chico, María Gabriela ; Medina Godoy, Xaviera Elizabeth ; Estupiñan Bazurto, Miliana Esperanza ; López Becerra, María José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c775-53b746dca72673a34ddfff8b7c9a605c2b360e62e1ff1afa412db201257575d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>González Chico, María Gabriela</creatorcontrib><creatorcontrib>Medina Godoy, Xaviera Elizabeth</creatorcontrib><creatorcontrib>Estupiñan Bazurto, Miliana Esperanza</creatorcontrib><creatorcontrib>López Becerra, María José</creatorcontrib><collection>CrossRef</collection><jtitle>Más Vita</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>González Chico, María Gabriela</au><au>Medina Godoy, Xaviera Elizabeth</au><au>Estupiñan Bazurto, Miliana Esperanza</au><au>López Becerra, María José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Botulinum Toxin in Treatments for Abnormal Movements</atitle><jtitle>Más Vita</jtitle><date>2024-07-02</date><risdate>2024</risdate><volume>6</volume><issue>2</issue><spage>82</spage><epage>92</epage><pages>82-92</pages><issn>2665-0150</issn><eissn>2665-0150</eissn><abstract>Introduction: Botulinum toxin is crucial for reducing sequelae in movement disorders such as Parkinson's. It blocks muscle contractions and improves quality of life, being used in both aesthetic and medical treatments. Methodology: A non-experimental longitudinal design was adopted, observing variables at multiple time points without manipulation. A mixed approach (qualitative and quantitative) was used with adults over 30 years old without Parkinson's history. The review included documents from PubMed, Scopus, and Scielo, applying rigorous inclusion and exclusion criteria. Objective: To evaluate the efficacy of botulinum toxin in treating abnormal movements in Parkinson's and understand its long-term effects. Results: Botulinum toxin type A reduces tremors by blocking acetylcholine. It improves motor symptoms of Parkinson's and essential tremor but requires frequent and costly treatments. There is a risk of developing antibodies that decrease its effectiveness. Discussion: It offers significant benefits, but its high cost and the need for frequent treatments are challenges. Patients report satisfaction in short-term studies, but more long-term research is needed. Conclusions: Promising for movement disorders, especially Parkinson's, although limited by cost and duration of effect. Future research should seek to extend therapeutic effects and reduce costs.</abstract><doi>10.47606/ACVEN/MV0235</doi><tpages>11</tpages><orcidid>https://orcid.org/0009-0009-7331-8590</orcidid><orcidid>https://orcid.org/0009-0001-3813-5790</orcidid><orcidid>https://orcid.org/0009-0007-0613-0016</orcidid><orcidid>https://orcid.org/0000-0001-9445-9004</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2665-0150
ispartof Más Vita, 2024-07, Vol.6 (2), p.82-92
issn 2665-0150
2665-0150
language eng
recordid cdi_crossref_primary_10_47606_ACVEN_MV0235
source EZB-FREE-00999 freely available EZB journals
title Botulinum Toxin in Treatments for Abnormal Movements
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A36%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Botulinum%20Toxin%20in%20Treatments%20for%20Abnormal%20Movements&rft.jtitle=M%C3%A1s%20Vita&rft.au=Gonz%C3%A1lez%20Chico,%20Mar%C3%ADa%20Gabriela&rft.date=2024-07-02&rft.volume=6&rft.issue=2&rft.spage=82&rft.epage=92&rft.pages=82-92&rft.issn=2665-0150&rft.eissn=2665-0150&rft_id=info:doi/10.47606/ACVEN/MV0235&rft_dat=%3Ccrossref%3E10_47606_ACVEN_MV0235%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true